Risk factors for acute graft‐versus‐host disease
暂无分享,去创建一个
R. Hoffmann | A. Rimm | R. Gale | J. Kersey | R. Good | E. Gluckman | J. Biggs | A. Marmont | T. Masaoka | F. Zwaan | M. Bortin | Eliane Gluckman | H. Kay | J. J. Rood | K. Dicke | D. Bekkum | Raymond G. Hoffmann | Robert Peter Gale | Mortimer M. Bortin | Dirk W. Bekkum | James C. Biggs | Karel A. Dicke | Robert A. Good | Humphrey E. M. Kay | John H. Kersey | Alberto Marmont | Tohru Masaoka | Alfred A. Rimm | Jon J. Rood | Ferdinand E. Zwaan
[1] R. Hoppe,et al. Engraftment of allogeneic bone marrow without graft-versus-host disease in mongrel dogs using total lymphoid irradiation. , 1980, Transplantation.
[2] J. Biggs,et al. Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum , 1986, British journal of haematology.
[3] H. Braine,et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. , 1982, Blood.
[4] Z. Fuks,et al. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation , 1978, The Journal of experimental medicine.
[5] H. Deeg,et al. Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.
[6] W. Elkins. Cellular Immunology and the Pathogenesis of Graft Versus Host Reactions (Part 1 of 3) , 1971 .
[7] R. Brookmeyer,et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. , 1983, The New England journal of medicine.
[8] V. Farewell,et al. Protective environment for marrow transplant recipients: a prospective study. , 1978, Annals of internal medicine.
[9] B. Nilsson,et al. DEATH BY GRAFT‐VERSUS‐HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMY , 1985, Transplantation.
[10] R. Gale,et al. ABH Antigens and Bone Marrow Transplantation , 1980, British journal of haematology.
[11] L. Robison,et al. A randomized study of the prevention of acute graft-versus-host disease. , 1982, The New England journal of medicine.
[12] J. Graham-Pole,et al. Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. , 1984, Blood.
[13] H. Braine,et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion , 1982 .
[14] Graft-versus-host disease after marrow transplantation. , 1984, Lancet.
[15] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[16] R. Gale,et al. GRAFT REJECTION AND GRAFT-VERSUS-HOST DISEASE: MIRROR IMAGES , 1986, The Lancet.
[17] R. Storb,et al. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. , 1977, The Journal of clinical investigation.
[18] G. Hutchins,et al. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. , 1978, The New England journal of medicine.
[19] H. Deeg,et al. Marrow transplantation for aplastic anemia. , 1974, Seminars in hematology.
[20] J. Fahey,et al. Immune interventions in disease. , 1987, Annals of internal medicine.
[21] A. Rimm,et al. Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. , 1983, JAMA.
[22] E. Gluckman,et al. Bone Marrow Transplantation in Severe Aplastic Anaemia: a Survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) * , 1981, British journal of haematology.
[23] R. Storb,et al. Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitis. , 1984, Experimental hematology.
[24] R. Storb,et al. Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids , 1981, American journal of hematology.
[25] S. Feig,et al. ABO blood group system and bone marrow transplantation , 1977 .
[26] D. Uphoff. Comparative survival of lethally irradiated inbred male mice inoculated with marrow from virgin or multiparous female donors. , 1975, Journal of the National Cancer Institute.
[27] K. Sullivan,et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. , 1983, The New England journal of medicine.
[28] A. Rimm,et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.
[29] W. Elkins. Cellular immunology and the pathogenesis of graft versus host reactions. , 1971, Progress in allergy.
[30] Mortensen Tm. Benzidine positive multicentric eosinophilic colonies in human blood mimicking erythroid bursts. , 1982 .
[31] E. Mellits,et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. , 1984, Blood.
[32] R. Storb,et al. Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients. , 1981, Transplantation.
[33] D. van der Waaij,et al. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. , 1974, Journal of the National Cancer Institute.
[34] A. Barrett,et al. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. , 1982, British medical journal.
[35] A. Rimm,et al. Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. , 1981, JAMA.
[36] W. J. Martin,et al. Cytomegalovirus infections associated with leukocyte transfusions. , 1980, Annals of internal medicine.
[37] E. Thomas,et al. Marrow transplantation for children with acute nonlymphoblastic leukemia in first remission. , 1981, Medical and pediatric oncology.
[38] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[39] J. Dowling,et al. Enhancement of murine cytomegalovirus infection during graft-vs.-host reaction. , 1977, The Journal of infectious diseases.
[40] P. Weiden. Graft-v-host disease following blood transfusions. , 1984, Archives of internal medicine.
[41] H. Deeg,et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. , 1986, Blood.
[42] A. Rimm,et al. Severe combined immunodeficiency disease: characterization of the disease and results of transplantation. , 1977, Transplantation proceedings.
[43] M. Bennett,et al. Effect of irradiated mouse spleen cells on severity of graft-versus-host disease. , 1978, Transplantation.
[44] A. Toivanen,et al. Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell products. , 2009, Scandinavian journal of haematology.
[45] H. Deeg,et al. Bone marrow transplantation in patients aged 45 years and older. , 1986, Blood.
[46] D. Karnofsky,et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .
[47] J. Shanley,et al. AUGMENTATION OF GRAFT‐VERSUS‐HOST REACTION BY CYTOMEGALOVIRUS INFECTION RESULTING IN INTERSTITIAL PNEUMONITIS , 1985, Transplantation.
[48] M. Simonsen. Graft‐versus‐Host‐Reactions: The History that never Was, and the Way Things Happened to Happen , 1985, Immunological reviews.
[49] D. Higby,et al. Graft-versus-host reaction following blood product transfusion. , 1982, The American journal of medicine.